AbbVie Inc.ABBVNYSE
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+9.6%
5Y CAGR+6.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+9.6%/yr
vs +2.4%/yr prior
5Y CAGR
+6.6%/yr
Consistent
Acceleration
+7.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
4 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.73 | +15.7% |
| 2024 | 6.69 | +13.0% |
| 2023 | 5.92 | +0.6% |
| 2022 | 5.88 | +7.4% |
| 2021 | 5.47 | -2.6% |
| 2020 | 5.62 | +18.0% |
| 2019 | 4.76 | -11.0% |
| 2018 | 5.35 | -17.3% |
| 2017 | 6.46 | +24.3% |
| 2016 | 5.20 | - |